| Primary |
| Product Used For Unknown Indication |
55.1% |
| Pain |
10.1% |
| Drug Use For Unknown Indication |
6.6% |
| Back Pain |
5.0% |
| Drug Abuse |
4.4% |
| Osteoarthritis |
3.2% |
| Hypertension |
1.7% |
| Analgesic Therapy |
1.7% |
| Depression |
1.7% |
| Drug Exposure During Pregnancy |
1.5% |
| Ill-defined Disorder |
1.2% |
| Rheumatoid Arthritis |
1.0% |
| Arthralgia |
1.0% |
| Diabetes Mellitus |
0.9% |
| Neuralgia |
0.9% |
| Urinary Tract Infection |
0.9% |
| Abdominal Pain |
0.9% |
| Foetal Exposure During Pregnancy |
0.8% |
| Procedural Pain |
0.7% |
| Musculoskeletal Pain |
0.6% |
|
| Vomiting |
15.7% |
| Toxicity To Various Agents |
15.2% |
| Serotonin Syndrome |
9.0% |
| Overdose |
7.9% |
| Drug Interaction |
5.5% |
| Withdrawal Syndrome |
5.0% |
| Death |
4.4% |
| Nausea |
4.4% |
| Tremor |
4.4% |
| Somnolence |
4.1% |
| Suicide Attempt |
3.8% |
| Completed Suicide |
2.6% |
| Unresponsive To Stimuli |
2.6% |
| Hypoglycaemia |
2.3% |
| Insomnia |
2.3% |
| Pain |
2.3% |
| Urticaria |
2.3% |
| Drug Ineffective |
2.0% |
| Multiple Drug Overdose |
2.0% |
| Squamous Cell Carcinoma |
2.0% |
|
| Secondary |
| Product Used For Unknown Indication |
34.2% |
| Pain |
12.2% |
| Osteoarthritis |
5.8% |
| Drug Use For Unknown Indication |
5.1% |
| Back Pain |
4.4% |
| Rheumatoid Arthritis |
4.4% |
| Drug Abuse |
4.0% |
| Osteoporosis |
3.5% |
| Myalgia |
3.4% |
| Hypertension |
3.1% |
| Hypermobility Syndrome |
2.9% |
| Depression |
2.8% |
| Fibromyalgia |
2.8% |
| Neuralgia |
2.8% |
| Analgesic Therapy |
1.6% |
| Neck Pain |
1.6% |
| Cancer Pain |
1.5% |
| Diabetes Mellitus |
1.4% |
| Arthritis |
1.3% |
| Muscle Spasms |
1.2% |
|
| Serotonin Syndrome |
11.4% |
| Vomiting |
11.0% |
| Suicidal Ideation |
8.8% |
| Drug Ineffective |
6.8% |
| Drug Hypersensitivity |
5.5% |
| Toxicity To Various Agents |
5.5% |
| Dizziness |
5.2% |
| Overdose |
5.2% |
| Withdrawal Syndrome |
4.9% |
| Squamous Cell Carcinoma |
4.5% |
| Rash |
3.9% |
| Completed Suicide |
3.6% |
| Suicide Attempt |
3.6% |
| Urinary Tract Infection |
3.6% |
| Respiratory Arrest |
3.2% |
| Nausea |
2.9% |
| Vision Blurred |
2.9% |
| Drug Interaction |
2.6% |
| Therapeutic Response Decreased |
2.6% |
| Convulsion |
2.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
27.1% |
| Pain |
14.0% |
| Hypertension |
8.4% |
| Rheumatoid Arthritis |
8.2% |
| Drug Use For Unknown Indication |
7.0% |
| Prophylaxis |
5.1% |
| Depression |
3.3% |
| Osteoporosis |
3.0% |
| Diabetes Mellitus |
2.9% |
| Constipation |
2.5% |
| Back Pain |
2.5% |
| Insomnia |
2.4% |
| Osteoarthritis |
2.2% |
| Gastrooesophageal Reflux Disease |
1.8% |
| Nausea |
1.7% |
| Abdominal Pain |
1.7% |
| Anxiety |
1.7% |
| Multiple Myeloma |
1.6% |
| Asthma |
1.5% |
| Hepatitis C |
1.5% |
|
| Vomiting |
11.5% |
| Pain |
8.6% |
| Weight Increased |
7.5% |
| Weight Decreased |
7.1% |
| Pulmonary Embolism |
6.9% |
| Nausea |
6.2% |
| Pain In Extremity |
5.6% |
| Pneumonia |
4.7% |
| Death |
4.4% |
| Myocardial Infarction |
4.2% |
| Rheumatoid Arthritis |
3.6% |
| White Blood Cell Count Decreased |
3.6% |
| Fatigue |
3.5% |
| Malaise |
3.5% |
| Thrombocytopenia |
3.5% |
| Drug Ineffective |
3.3% |
| Rash |
3.1% |
| Sepsis |
3.1% |
| Urinary Tract Infection |
3.1% |
| Vision Blurred |
3.1% |
|
| Interacting |
| Product Used For Unknown Indication |
36.9% |
| Pain |
7.7% |
| Type 2 Diabetes Mellitus |
7.7% |
| Back Pain |
6.2% |
| Depression |
6.2% |
| Hypertension |
5.4% |
| Neuralgia |
4.6% |
| Bacterial Infection |
3.1% |
| Osteoarthritis |
3.1% |
| Rheumatoid Arthritis |
3.1% |
| Arthralgia |
2.3% |
| Asthma |
1.5% |
| Breakthrough Pain |
1.5% |
| Hypercholesterolaemia |
1.5% |
| Ischaemic Stroke |
1.5% |
| Multiple Sclerosis |
1.5% |
| Myofascial Pain Syndrome |
1.5% |
| Polyneuropathy |
1.5% |
| Prophylaxis |
1.5% |
| Sciatica |
1.5% |
|
| Drug Interaction |
24.2% |
| Serotonin Syndrome |
12.1% |
| Pulmonary Oedema |
6.1% |
| Rash |
6.1% |
| Urinary Retention |
6.1% |
| Accidental Overdose |
3.0% |
| Amnesia |
3.0% |
| Coma |
3.0% |
| Depressed Level Of Consciousness |
3.0% |
| Drug Level Increased |
3.0% |
| Drug Toxicity |
3.0% |
| Hypercreatininaemia |
3.0% |
| Hypoglycaemia |
3.0% |
| Inappropriate Antidiuretic Hormone Secretion |
3.0% |
| Overdose |
3.0% |
| Renal Failure Acute |
3.0% |
| Respiratory Failure |
3.0% |
| Somnolence |
3.0% |
| Syncope |
3.0% |
| Tachycardia |
3.0% |
|
